Toxic shock syndrome and streptococcal myositis: Three case reports

European Journal of Pediatrics

Volumn 161, Issue 9, 2002, Pages 497-498

  Watkins, Ryan ^a   Vyas, Harish ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Myositis; Septic shock; Streptococcus pyogenes

Indexed keywords

ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INTENSIVE CARE; MALE; MYOSITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CLINDAMYCIN; FEMALE; HUMANS; IMMUNOGLOBULINS; INFANT; INTENSIVE CARE; MALE; METRONIDAZOLE; MYOSITIS; PENICILLINS; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0036050903     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-002-1032-7     Document Type: Article

References (7)

1. Severe invasive group A streptococcal infections: A subject review
2. Risk factors in the pathogenesis of invasive group A streptococcal infections: Role of protective humoral immunity
3. Pathogenesis of group A streptococcal infections
4. Clinical usefulness of intravenous human immunoglobulins in invasive group A streptococcal infections: Case report and review
5. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates
6. The flesh-eating bacterium: What's next?
7. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection